{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T05:54:22Z","timestamp":1786946062271,"version":"build-2736575974"},"reference-count":83,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T00:00:00Z","timestamp":1747785600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T00:00:00Z","timestamp":1747785600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82470154"],"award-info":[{"award-number":["82470154"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82100154"],"award-info":[{"award-number":["82100154"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82200245"],"award-info":[{"award-number":["82200245"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82104447"],"award-info":[{"award-number":["82104447"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-025-06615-y","type":"journal-article","created":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T04:36:52Z","timestamp":1747802212000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Establishment of a prognostic model based on ER stress-related cell death genes and proposing a novel combination therapy in acute myeloid leukemia"],"prefix":"10.1186","volume":"23","author":[{"given":"Minghui","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huajian","family":"Xian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoli","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zixuan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaoqun","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuling","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yixin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shufeng","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renyao","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YaoYifu","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruiheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huijian","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guorui","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0022-1861","authenticated-orcid":false,"given":"Han","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,21]]},"reference":[{"issue":"3","key":"6615_CR1","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1002\/ajh.26822","volume":"98","author":"S Shimony","year":"2023","unstructured":"Shimony S, Stahl M, Stone RM. Acute myeloid leukemia: 2023 update on diagnosis, risk-stratification, and management. Am J Hematol. 2023;98(3):502\u201326.","journal-title":"Am J Hematol"},{"issue":"2","key":"6615_CR2","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/s41571-018-0156-2","volume":"16","author":"CD DiNardo","year":"2019","unstructured":"DiNardo CD, Perl AE. Advances in patient care through increasingly individualized therapy. Nat Rev Clin Oncol. 2019;16(2):73\u20134.","journal-title":"Nat Rev Clin Oncol"},{"issue":"11","key":"6615_CR3","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.3390\/ph16111614","volume":"16","author":"S Tseng","year":"2023","unstructured":"Tseng S, Lee M-E, Lin P-C. A review of childhood acute myeloid leukemia: diagnosis and novel treatment. Pharmaceuticals. 2023;16(11):1614.","journal-title":"Pharmaceuticals"},{"issue":"1","key":"6615_CR4","doi-asserted-by":"publisher","first-page":"46","DOI":"10.3322\/caac.21873","volume":"75","author":"HM Kantarjian","year":"2025","unstructured":"Kantarjian HM, DiNardo CD, Kadia TM, Daver NG, Altman JK, Stein EM, et al. Acute myeloid leukemia management and research in 2025. CA Cancer J Clin. 2025;75(1):46\u201367.","journal-title":"CA Cancer J Clin"},{"key":"6615_CR5","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n2026","volume":"375","author":"LF Newell","year":"2021","unstructured":"Newell LF, Cook RJ. Advances in acute myeloid leukemia. BMJ. 2021;375: n2026.","journal-title":"BMJ"},{"issue":"4","key":"6615_CR6","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1158\/2159-8290.CD-19-1011","volume":"10","author":"NJ Short","year":"2020","unstructured":"Short NJ, Konopleva M, Kadia TM, Borthakur G, Ravandi F, DiNardo CD, et al. Advances in the treatment of acute myeloid leukemia: new drugs and new challenges. Cancer Discov. 2020;10(4):506\u201325.","journal-title":"Cancer Discov"},{"issue":"2","key":"6615_CR7","doi-asserted-by":"publisher","first-page":"308","DOI":"10.3324\/haematol.2022.280801","volume":"108","author":"S Kayser","year":"2023","unstructured":"Kayser S, Levis MJ. The clinical impact of the molecular landscape of acute myeloid leukemia. Haematologica. 2023;108(2):308\u201320.","journal-title":"Haematologica"},{"issue":"12","key":"6615_CR8","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1182\/blood.2022016867","volume":"140","author":"H D\u00f6hner","year":"2022","unstructured":"D\u00f6hner H, Wei AH, Appelbaum FR, Craddock C, DiNardo CD, Dombret H, et al. Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN. Blood. 2022;140(12):1345\u201377.","journal-title":"Blood"},{"issue":"7633","key":"6615_CR9","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1038\/nature20598","volume":"540","author":"SW Ng","year":"2016","unstructured":"Ng SW, Mitchell A, Kennedy JA, Chen WC, McLeod J, Ibrahimova N, et al. A 17-gene stemness score for rapid determination of risk in acute leukaemia. Nature. 2016;540(7633):433\u20137.","journal-title":"Nature"},{"issue":"7","key":"6615_CR10","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1158\/2159-8290.CD-16-0441","volume":"7","author":"T Farge","year":"2017","unstructured":"Farge T, Saland E, de Toni F, Aroua N, Hosseini M, Perry R, et al. Chemotherapy-resistant human acute myeloid leukemia cells are not enriched for leukemic stem cells but require oxidative metabolism. Cancer Discov. 2017;7(7):716\u201335.","journal-title":"Cancer Discov"},{"issue":"3","key":"6615_CR11","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.ccell.2018.08.007","volume":"34","author":"AL Boyd","year":"2018","unstructured":"Boyd AL, Aslostovar L, Reid J, Ye W, Tanasijevic B, Porras DP, et al. Identification of chemotherapy-induced leukemic-regenerating cells reveals a transient vulnerability of human AML recurrence. Cancer Cell. 2018;34(3):483-98.e5.","journal-title":"Cancer Cell"},{"issue":"1","key":"6615_CR12","first-page":"27","volume":"4","author":"A Lasry","year":"2023","unstructured":"Lasry A, Nadorp B, Fornerod M, Nicolet D, Wu H, Walker CJ, et al. An inflammatory state remodels the immune microenvironment and improves risk stratification in acute myeloid leukemia. Nat Cancer. 2023;4(1):27\u201342.","journal-title":"Nat Cancer"},{"key":"6615_CR13","doi-asserted-by":"crossref","unstructured":"Rutella S, Vadakekolathu J, Mazziotta F, Reeder S, Yau TO, Mukhopadhyay R, et al. Immune dysfunction signatures predict outcomes and define checkpoint blockade-unresponsive microenvironments in acute myeloid leukemia. J Clin Invest. 2022;132(21).","DOI":"10.1172\/JCI159579"},{"issue":"1","key":"6615_CR14","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.cmet.2015.12.006","volume":"23","author":"N Pavlova Natalya","year":"2016","unstructured":"Pavlova Natalya N, Thompson CB. The emerging hallmarks of cancer metabolism. Cell Metab. 2016;23(1):27\u201347.","journal-title":"Cell Metab"},{"issue":"1","key":"6615_CR15","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1038\/s41420-024-02110-3","volume":"10","author":"W Zhang","year":"2024","unstructured":"Zhang W, Shi Y, Oyang L, Cui S, Li S, Li J, et al. Endoplasmic reticulum stress-a key guardian in cancer. Cell Death Discov. 2024;10(1):343.","journal-title":"Cell Death Discov"},{"issue":"2","key":"6615_CR16","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/nrm3270","volume":"13","author":"C Hetz","year":"2012","unstructured":"Hetz C. The unfolded protein response: controlling cell fate decisions under ER stress and beyond. Nat Rev Mol Cell Biol. 2012;13(2):89\u2013102.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"2","key":"6615_CR17","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.molcel.2017.06.017","volume":"69","author":"C Hetz","year":"2018","unstructured":"Hetz C, Papa FR. The unfolded protein response and cell fate control. Mol Cell. 2018;69(2):169\u201381.","journal-title":"Mol Cell"},{"issue":"2","key":"6615_CR18","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/s41568-020-00312-2","volume":"21","author":"X Chen","year":"2020","unstructured":"Chen X, Cubillos-Ruiz JR. Endoplasmic reticulum stress signals in the tumour and its microenvironment. Nat Rev Cancer. 2020;21(2):71\u201388.","journal-title":"Nat Rev Cancer"},{"key":"6615_CR19","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s11658-020-00212-1","volume":"25","author":"S Bartoszewska","year":"2020","unstructured":"Bartoszewska S, Collawn JF. Unfolded protein response (UPR) integrated signaling networks determine cell fate during hypoxia. Cell Mol Biol Lett. 2020;25:18.","journal-title":"Cell Mol Biol Lett"},{"issue":"11","key":"6615_CR20","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1016\/j.trecan.2020.05.012","volume":"6","author":"A Khateb","year":"2020","unstructured":"Khateb A, Ronai ZA. Unfolded protein response in leukemia: from basic understanding to therapeutic opportunities. Trends Cancer. 2020;6(11):960\u201373.","journal-title":"Trends Cancer"},{"issue":"1","key":"6615_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbamcr.2024.119869","volume":"1872","author":"H Liao","year":"2025","unstructured":"Liao H, Liu S, Ma Q, Huang H, Goel A, Torabian P, et al. Endoplasmic reticulum stress induced autophagy in cancer and its potential interactions with apoptosis and ferroptosis. Biochim Biophys Acta Mol Cell Res. 2025;1872(1): 119869.","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"key":"6615_CR22","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.semcancer.2019.11.007","volume":"66","author":"M Bhardwaj","year":"2020","unstructured":"Bhardwaj M, Leli NM, Koumenis C, Amaravadi RK. Regulation of autophagy by canonical and non-canonical ER stress responses. Semin Cancer Biol. 2020;66:116\u201328.","journal-title":"Semin Cancer Biol"},{"issue":"48","key":"6615_CR23","doi-asserted-by":"publisher","first-page":"49689","DOI":"10.1074\/jbc.C400261200","volume":"279","author":"F Gu","year":"2004","unstructured":"Gu F, Nguy\u00ean DT, Stuible M, Dub\u00e9 N, Tremblay ML, Chevet E. Protein-tyrosine phosphatase 1B potentiates IRE1 signaling during endoplasmic reticulum stress. J Biol Chem. 2004;279(48):49689\u201393.","journal-title":"J Biol Chem"},{"issue":"3","key":"6615_CR24","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1038\/s41556-019-0285-6","volume":"21","author":"L Liu","year":"2019","unstructured":"Liu L, Zhao M, Jin X, Ney G, Yang KB, Peng F, et al. Adaptive endoplasmic reticulum stress signalling via IRE1\u03b1-XBP1 preserves self-renewal of haematopoietic and pre-leukaemic stem cells. Nat Cell Biol. 2019;21(3):328\u201337.","journal-title":"Nat Cell Biol"},{"key":"6615_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2022.100853","volume":"64","author":"M \u015aniegocka","year":"2022","unstructured":"\u015aniegocka M, Liccardo F, Fazi F, Masciarelli S. Understanding ER homeostasis and the UPR to enhance treatment efficacy of acute myeloid leukemia. Drug Resist Updat. 2022;64: 100853.","journal-title":"Drug Resist Updat"},{"issue":"3","key":"6615_CR26","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.stem.2012.12.013","volume":"12","author":"ED Lagadinou","year":"2013","unstructured":"Lagadinou ED, Sach A, Callahan K, Rossi RM, Neering SJ, Minhajuddin M, et al. BCL-2 inhibition targets oxidative phosphorylation and selectively eradicates quiescent human leukemia stem cells. Cell Stem Cell. 2013;12(3):329\u201341.","journal-title":"Cell Stem Cell"},{"issue":"1","key":"6615_CR27","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/s41568-021-00407-4","volume":"22","author":"ST Diepstraten","year":"2022","unstructured":"Diepstraten ST, Anderson MA, Czabotar PE, Lessene G, Strasser A, Kelly GL. The manipulation of apoptosis for cancer therapy using BH3-mimetic drugs. Nat Rev Cancer. 2022;22(1):45\u201364.","journal-title":"Nat Rev Cancer"},{"issue":"14","key":"6615_CR28","doi-asserted-by":"publisher","first-page":"18736","DOI":"10.18632\/oncotarget.7702","volume":"7","author":"H Sun","year":"2016","unstructured":"Sun H, Lin DC, Guo X, Kharabi Masouleh B, Gery S, Cao Q, et al. Inhibition of IRE1\u03b1-driven pro-survival pathways is a promising therapeutic application in acute myeloid leukemia. Oncotarget. 2016;7(14):18736\u201349.","journal-title":"Oncotarget"},{"issue":"2","key":"6615_CR29","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.stem.2015.06.002","volume":"17","author":"X Cai","year":"2015","unstructured":"Cai X, Gao L, Teng L, Ge J, Oo ZM, Kumar AR, et al. Runx1 deficiency decreases ribosome biogenesis and confers stress resistance to hematopoietic stem and progenitor cells. Cell Stem Cell. 2015;17(2):165\u201377.","journal-title":"Cell Stem Cell"},{"issue":"12","key":"6615_CR30","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1016\/j.trecan.2024.09.011","volume":"10","author":"H Urra","year":"2024","unstructured":"Urra H, Aravena R, Gonz\u00e1lez-Johnson L, Hetz C. The UPRising connection between endoplasmic reticulum stress and the tumor microenvironment. Trends Cancer. 2024;10(12):1161\u201373.","journal-title":"Trends Cancer"},{"issue":"4","key":"6615_CR31","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1038\/s41375-018-0254-2","volume":"33","author":"B Doron","year":"2019","unstructured":"Doron B, Abdelhamed S, Butler JT, Hashmi SK, Horton TM, Kurre P. Transmissible ER stress reconfigures the AML bone marrow compartment. Leukemia. 2019;33(4):918\u201330.","journal-title":"Leukemia"},{"key":"6615_CR32","doi-asserted-by":"crossref","unstructured":"Wang ES, Fay HRS, Dykstra KM, Phelps MN, Johnson M, Harrigan A, et al. Autophagy inhibition induces AML cell death and enhances the efficacy of chemotherapy under hypoxia. bioRxiv. 2024.","DOI":"10.1101\/2024.11.24.625107"},{"issue":"6","key":"6615_CR33","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1038\/onc.2017.376","volume":"37","author":"Q Heydt","year":"2018","unstructured":"Heydt Q, Larrue C, Saland E, Bertoli S, Sarry JE, Besson A, et al. Oncogenic FLT3-ITD supports autophagy via ATF4 in acute myeloid leukemia. Oncogene. 2018;37(6):787\u201397.","journal-title":"Oncogene"},{"issue":"2","key":"6615_CR34","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/s41568-020-00312-2","volume":"21","author":"X Chen","year":"2021","unstructured":"Chen X, Cubillos-Ruiz JR. Endoplasmic reticulum stress signals in the tumour and its microenvironment. Nat Rev Cancer. 2021;21(2):71\u201388.","journal-title":"Nat Rev Cancer"},{"issue":"26","key":"6615_CR35","doi-asserted-by":"publisher","first-page":"3113","DOI":"10.1182\/blood-2016-08-731737","volume":"128","author":"J Fucikova","year":"2016","unstructured":"Fucikova J, Truxova I, Hensler M, Becht E, Kasikova L, Moserova I, et al. Calreticulin exposure by malignant blasts correlates with robust anticancer immunity and improved clinical outcome in AML patients. Blood. 2016;128(26):3113\u201324.","journal-title":"Blood"},{"issue":"3","key":"6615_CR36","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1038\/s41418-017-0012-4","volume":"25","author":"L Galluzzi","year":"2018","unstructured":"Galluzzi L, Vitale I, Aaronson SA, Abrams JM, Adam D, Agostinis P, et al. Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018. Cell Death Differ. 2018;25(3):486\u2013541.","journal-title":"Cell Death Differ"},{"issue":"2","key":"6615_CR37","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.cell.2023.11.044","volume":"187","author":"K Newton","year":"2024","unstructured":"Newton K, Strasser A, Kayagaki N, Dixit VM. Cell death. Cell. 2024;187(2):235\u201356.","journal-title":"Cell"},{"issue":"18","key":"6615_CR38","doi-asserted-by":"publisher","first-page":"4033","DOI":"10.1158\/1078-0432.CCR-22-1618","volume":"28","author":"P Jin","year":"2022","unstructured":"Jin P, Jin Q, Wang X, Zhao M, Dong F, Jiang G, et al. Large-scale in vitro and in vivo CRISPR-Cas9 knockout screens identify a 16-gene fitness score for improved risk assessment in acute myeloid leukemia. Clin Cancer Res. 2022;28(18):4033\u201344.","journal-title":"Clin Cancer Res"},{"key":"6615_CR39","doi-asserted-by":"publisher","first-page":"1149513","DOI":"10.3389\/fimmu.2023.1149513","volume":"14","author":"G Jiang","year":"2023","unstructured":"Jiang G, Jin P, Xiao X, Shen J, Li R, Zhang Y, et al. Identification and validation of a novel CD8+ T cell-associated prognostic model based on ferroptosis in acute myeloid leukemia. Front Immunol. 2023;14:1149513.","journal-title":"Front Immunol"},{"key":"6615_CR40","doi-asserted-by":"publisher","first-page":"1408109","DOI":"10.3389\/fimmu.2024.1408109","volume":"15","author":"Z Li","year":"2024","unstructured":"Li Z, Jin P, Xiang R, Li X, Shen J, He M, et al. A CD8(+) T cell related immune score predicts survival and refines the risk assessment in acute myeloid leukemia. Front Immunol. 2024;15:1408109.","journal-title":"Front Immunol"},{"key":"6615_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijsu.2022.106936","volume":"107","author":"Y Zou","year":"2022","unstructured":"Zou Y, Xie J, Zheng S, Liu W, Tang Y, Tian W, et al. Leveraging diverse cell-death patterns to predict the prognosis and drug sensitivity of triple-negative breast cancer patients after surgery. Int J Surg. 2022;107: 106936.","journal-title":"Int J Surg"},{"issue":"1","key":"6615_CR42","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1186\/s12967-023-04468-x","volume":"21","author":"H Qin","year":"2023","unstructured":"Qin H, Abulaiti A, Maimaiti A, Abulaiti Z, Fan G, Aili Y, et al. Integrated machine learning survival framework develops a prognostic model based on inter-crosstalk definition of mitochondrial function and cell death patterns in a large multicenter cohort for lower-grade glioma. J Transl Med. 2023;21(1):588.","journal-title":"J Transl Med"},{"key":"6615_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2023.104920","volume":"99","author":"K Cao","year":"2024","unstructured":"Cao K, Zhu J, Lu M, Zhang J, Yang Y, Ling X, et al. Analysis of multiple programmed cell death-related prognostic genes and functional validations of necroptosis-associated genes in oesophageal squamous cell carcinoma. EBioMedicine. 2024;99: 104920.","journal-title":"EBioMedicine"},{"issue":"12","key":"6615_CR44","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15(12):550.","journal-title":"Genome Biol"},{"key":"6615_CR45","doi-asserted-by":"publisher","first-page":"2798","DOI":"10.1016\/j.csbj.2024.06.035","volume":"23","author":"H Liu","year":"2024","unstructured":"Liu H, Zhang W, Zhang Y, Adegboro AA, Fasoranti DO, Dai L, et al. Mime: a flexible machine-learning framework to construct and visualize models for clinical characteristics prediction and feature selection. Comput Struct Biotechnol J. 2024;23:2798\u2013810.","journal-title":"Comput Struct Biotechnol J"},{"issue":"12","key":"6615_CR46","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1093\/bioinformatics\/btq170","volume":"26","author":"MD Wilkerson","year":"2010","unstructured":"Wilkerson MD, Hayes DN. ConsensusClusterPlus: a class discovery tool with confidence assessments and item tracking. Bioinformatics. 2010;26(12):1572\u20133.","journal-title":"Bioinformatics"},{"issue":"5","key":"6615_CR47","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nmeth.3337","volume":"12","author":"AM Newman","year":"2015","unstructured":"Newman AM, Liu CL, Green MR, Gentles AJ, Feng W, Xu Y, et al. Robust enumeration of cell subsets from tissue expression profiles. Nat Methods. 2015;12(5):453\u20137.","journal-title":"Nat Methods"},{"key":"6615_CR48","doi-asserted-by":"crossref","unstructured":"Foroutan M, Bhuva DD, Lyu R, Horan K, Cursons J, Davis MJ. Single sample scoring of molecular phenotypes. BMC Bioinform. 2018;19(1).","DOI":"10.1186\/s12859-018-2435-4"},{"key":"6615_CR49","doi-asserted-by":"crossref","unstructured":"Yoshihara K, Shahmoradgoli M, Mart\u00ednez E, Vegesna R, Kim H, Torres-Garcia W, et al. Inferring tumour purity and stromal and immune cell admixture from expression data. Nat Commun. 2013;4(1).","DOI":"10.1038\/ncomms3612"},{"key":"6615_CR50","doi-asserted-by":"crossref","unstructured":"Maeser D, Gruener RF, Huang RS. oncoPredict: an R package for predicting in vivo or cancer patient drug response and biomarkers from cell line screening data. Briefings Bioinform. 2021;22(6).","DOI":"10.1093\/bib\/bbab260"},{"key":"6615_CR51","doi-asserted-by":"crossref","unstructured":"Fu J, Li K, Zhang W, Wan C, Zhang J, Jiang P, et al. Large-scale public data reuse to model immunotherapy response and resistance. Genome Med. 2020;12(1).","DOI":"10.1186\/s13073-020-0721-z"},{"issue":"11","key":"6615_CR52","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1002\/ajh.26309","volume":"96","author":"Z Chen","year":"2021","unstructured":"Chen Z, Song J, Wang W, Bai J, Zhang Y, Shi J, et al. A novel 4-mRNA signature predicts the overall survival in acute myeloid leukemia. Am J Hematol. 2021;96(11):1385\u201395.","journal-title":"Am J Hematol"},{"issue":"9","key":"6615_CR53","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1038\/s41571-021-00509-w","volume":"18","author":"H D\u00f6hner","year":"2021","unstructured":"D\u00f6hner H, Wei AH, L\u00f6wenberg B. Towards precision medicine for AML. Nat Rev Clin Oncol. 2021;18(9):577\u201390.","journal-title":"Nat Rev Clin Oncol"},{"key":"6615_CR54","doi-asserted-by":"crossref","unstructured":"Hackl H, Astanina K, Wieser R. Molecular and genetic alterations associated with therapy resistance and relapse of acute myeloid leukemia. J Hematol Oncol. 2017;10(1).","DOI":"10.1186\/s13045-017-0416-0"},{"key":"6615_CR55","doi-asserted-by":"crossref","unstructured":"Myo Min KK, Ffrench CB, McClure BJ, Ortiz M, Dorward EL, Samuel MS, et al. Desmoglein-2 as a cancer modulator: friend or foe? Front Oncol. 2023;13.","DOI":"10.3389\/fonc.2023.1327478"},{"issue":"20","key":"6615_CR56","doi-asserted-by":"publisher","first-page":"4527","DOI":"10.1158\/0008-5472.CAN-20-0531","volume":"80","author":"CH Nguyen","year":"2020","unstructured":"Nguyen CH, Schlerka A, Grandits AM, Koller E, van der Kouwe E, Vassiliou GS, et al. IL2RA promotes aggressiveness and stem cell-related properties of acute myeloid leukemia. Can Res. 2020;80(20):4527\u201339.","journal-title":"Can Res"},{"issue":"2","key":"6615_CR57","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s12192-014-0548-x","volume":"20","author":"D Scieglinska","year":"2015","unstructured":"Scieglinska D, Krawczyk Z. Expression, function, and regulation of the testis-enriched heat shock HSPA2 gene in rodents and humans. Cell Stress Chaperones. 2015;20(2):221\u201335.","journal-title":"Cell Stress Chaperones"},{"key":"6615_CR58","doi-asserted-by":"publisher","first-page":"110663","DOI":"10.1016\/j.biopha.2020.110663","volume":"131","author":"Y He","year":"2020","unstructured":"He Y, Zhou C, Huang M, Tang C, Liu X, Yue Y, et al. Glyoxalase system: a systematic review of its biological activity, related-diseases, screening methods and small molecule regulators. Biomed Pharmacother. 2020;131:110663.","journal-title":"Biomed Pharmacother"},{"issue":"2","key":"6615_CR59","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1038\/s12276-022-00735-x","volume":"54","author":"N Zhang","year":"2022","unstructured":"Zhang N, Shen Y, Li H, Chen Y, Zhang P, Lou S, et al. The m6A reader IGF2BP3 promotes acute myeloid leukemia progression by enhancing RCC2 stability. Exp Mol Med. 2022;54(2):194\u2013205.","journal-title":"Exp Mol Med"},{"issue":"11","key":"6615_CR60","doi-asserted-by":"publisher","first-page":"9423","DOI":"10.3390\/ijms24119423","volume":"24","author":"X Liu","year":"2023","unstructured":"Liu X, Chen J, Chen W, Xu Y, Shen Y, Xu X. Targeting IGF2BP3 in Cancer. Int J Mol Sci. 2023;24(11):9423.","journal-title":"Int J Mol Sci"},{"issue":"8","key":"6615_CR61","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1080\/17460441.2022.2090541","volume":"17","author":"ABA Jailani","year":"2022","unstructured":"Jailani ABA, Bigos KJA, Avgoustou P, Egan JL, Hathway RA, Skerry TM, et al. Targeting the adrenomedullin-2 receptor for the discovery and development of novel anti-cancer agents. Expert Opin Drug Discov. 2022;17(8):839\u201348.","journal-title":"Expert Opin Drug Discov"},{"issue":"2","key":"6615_CR62","doi-asserted-by":"publisher","first-page":"219","DOI":"10.2174\/1570159X20666220922153903","volume":"21","author":"S Koerich","year":"2023","unstructured":"Koerich S, Parreira GM, de Almeida DL, Vieira RP, de Oliveira ACP. Receptors for Advanced Glycation End Products (RAGE): promising targets aiming at the treatment of neurodegenerative conditions. Curr Neuropharmacol. 2023;21(2):219\u201334.","journal-title":"Curr Neuropharmacol"},{"key":"6615_CR63","doi-asserted-by":"crossref","unstructured":"Rouhiainen A, Kuja-Panula J, Tumova S, Rauvala H. RAGE-mediated cell signaling. Calcium-Binding Proteins and RAGE. Methods Mol Biol 2013. p. 239\u201363.","DOI":"10.1007\/978-1-62703-230-8_15"},{"issue":"1","key":"6615_CR64","doi-asserted-by":"publisher","first-page":"132","DOI":"10.3390\/antiox13010132","volume":"13","author":"W Lin","year":"2024","unstructured":"Lin W, Chen H, Chen X, Guo C. The roles of neutrophil-derived myeloperoxidase (MPO) in diseases: the new progress. Antioxidants. 2024;13(1):132.","journal-title":"Antioxidants"},{"issue":"20","key":"6615_CR65","doi-asserted-by":"publisher","first-page":"5191","DOI":"10.1158\/0008-5472.CAN-19-0515","volume":"79","author":"M Hosseini","year":"2019","unstructured":"Hosseini M, Rezvani HR, Aroua N, Bosc C, Farge T, Saland E, et al. Targeting myeloperoxidase disrupts mitochondrial redox balance and overcomes cytarabine resistance in human acute myeloid leukemia. Can Res. 2019;79(20):5191\u2013203.","journal-title":"Can Res"},{"key":"6615_CR66","unstructured":"Ellisen LW. mTOR Regulation through the REDD1-TSC Pathway. Cell Cycle. 2005."},{"issue":"1","key":"6615_CR67","doi-asserted-by":"publisher","first-page":"36850421997273","DOI":"10.1177\/0036850421997273","volume":"104","author":"F Ding","year":"2021","unstructured":"Ding F, Gao F, Zhang S, Lv X, Chen Y, Liu Q. A review of the mechanism of DDIT4 serve as a mitochondrial related protein in tumor regulation. Sci Prog. 2021;104(1):36850421997273.","journal-title":"Sci Prog"},{"issue":"5","key":"6615_CR68","doi-asserted-by":"publisher","first-page":"C807","DOI":"10.1152\/ajpcell.00340.2020","volume":"319","author":"FA Britto","year":"2020","unstructured":"Britto FA, Dumas K, Giorgetti-Peraldi S, Ollendorff V, Favier FB. Is REDD1 a metabolic double agent? Lessons from physiology and pathology. Am J Physiol Cell Physiol. 2020;319(5):C807\u201324.","journal-title":"Am J Physiol Cell Physiol"},{"key":"6615_CR69","doi-asserted-by":"crossref","unstructured":"Tirado-Hurtado I, Fajardo W, Pinto JA. DNA damage inducible transcript 4 gene: the switch of the metabolism as potential target in cancer. Front Oncol. 2018;8.","DOI":"10.3389\/fonc.2018.00106"},{"issue":"1","key":"6615_CR70","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/nrm3025","volume":"12","author":"R Zoncu","year":"2010","unstructured":"Zoncu R, Efeyan A, Sabatini DM. mTOR: from growth signal integration to cancer, diabetes and ageing. Nat Rev Mol Cell Biol. 2010;12(1):21\u201335.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"5","key":"6615_CR71","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/s41416-018-0368-3","volume":"120","author":"M Foltyn","year":"2019","unstructured":"Foltyn M, Luger AL, Lorenz NI, Sauer B, Mittelbronn M, Harter PN, et al. The physiological mTOR complex 1 inhibitor DDIT4 mediates therapy resistance in glioblastoma. Br J Cancer. 2019;120(5):481\u20137.","journal-title":"Br J Cancer"},{"issue":"1","key":"6615_CR72","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.canlet.2016.03.005","volume":"375","author":"DJ Barakat","year":"2016","unstructured":"Barakat DJ, Mendonca J, Barberi T, Zhang J, Kachhap SK, Paz-Priel I, et al. C\/EBP\u03b2 regulates sensitivity to bortezomib in prostate cancer cells by inducing REDD1 and autophagosome-lysosome fusion. Cancer Lett. 2016;375(1):152\u201361.","journal-title":"Cancer Lett"},{"issue":"1","key":"6615_CR73","first-page":"1","volume":"38","author":"F Du","year":"2018","unstructured":"Du F, Sun L, Chu Y, Li T, Lei C, Wang X, et al. DDIT4 promotes gastric cancer proliferation and tumorigenesis through the p53 and MAPK pathways. Cancer Commun. 2018;38(1):1\u201314.","journal-title":"Cancer Commun"},{"issue":"45","key":"6615_CR74","doi-asserted-by":"publisher","first-page":"5904","DOI":"10.1038\/onc.2008.271","volume":"27","author":"TL Whiteside","year":"2008","unstructured":"Whiteside TL. The tumor microenvironment and its role in promoting tumor growth. Oncogene. 2008;27(45):5904\u201312.","journal-title":"Oncogene"},{"issue":"7637","key":"6615_CR75","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/nature21349","volume":"541","author":"DS Chen","year":"2017","unstructured":"Chen DS, Mellman I. Elements of cancer immunity and the cancer\u2013immune set point. Nature. 2017;541(7637):321\u201330.","journal-title":"Nature"},{"issue":"1","key":"6615_CR76","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.immuni.2018.06.006","volume":"49","author":"J Li","year":"2018","unstructured":"Li J, Byrne KT, Yan F, Yamazoe T, Chen Z, Baslan T, et al. Tumor cell-intrinsic factors underlie heterogeneity of immune cell infiltration and response to immunotherapy. Immunity. 2018;49(1):178-93.e7.","journal-title":"Immunity"},{"key":"6615_CR77","doi-asserted-by":"publisher","first-page":"174459","DOI":"10.1016\/j.ejphar.2021.174459","volume":"910","author":"H Jiang","year":"2021","unstructured":"Jiang H, Li Y, Xiang X, Tang Z, Liu K, Su Q, et al. Chaetocin: A review of its anticancer potentials and mechanisms. Eur J Pharmacol. 2021;910:174459.","journal-title":"Eur J Pharmacol"},{"issue":"4","key":"6615_CR78","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1093\/neuonc\/noad222","volume":"26","author":"DE Xin","year":"2024","unstructured":"Xin DE, Liao Y, Rao R, Ogurek S, Sengupta S, Xin M, et al. Chaetocin-mediated SUV39H1 inhibition targets stemness and oncogenic networks of diffuse midline gliomas and synergizes with ONC201. Neuro Oncol. 2024;26(4):735\u201348.","journal-title":"Neuro Oncol"},{"issue":"1","key":"6615_CR79","doi-asserted-by":"publisher","first-page":"73","DOI":"10.4062\/biomolther.2020.012","volume":"29","author":"B Lian","year":"2021","unstructured":"Lian B, Lin Q, Tang W, Qi X, Li J. SUV39H1 is a new client protein of Hsp90 degradated by chaetocin as a novel C-terminal inhibitor of Hsp90. Biomol Ther. 2021;29(1):73\u201382.","journal-title":"Biomol Ther"},{"issue":"5","key":"6615_CR80","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1038\/leu.2016.329","volume":"31","author":"C Zhou","year":"2016","unstructured":"Zhou C, Martinez E, Di Marcantonio D, Solanki-Patel N, Aghayev T, Peri S, et al. JUN is a key transcriptional regulator of the unfolded protein response in acute myeloid leukemia. Leukemia. 2016;31(5):1196\u2013205.","journal-title":"Leukemia"},{"key":"6615_CR81","doi-asserted-by":"publisher","DOI":"10.1016\/j.blre.2024.101195","volume":"65","author":"DJ Fowler-Shorten","year":"2024","unstructured":"Fowler-Shorten DJ, Hellmich C, Markham M, Bowles KM, Rushworth SA. BCL-2 inhibition in haematological malignancies: clinical application and complications. Blood Rev. 2024;65: 101195.","journal-title":"Blood Rev"},{"key":"6615_CR82","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.115820","volume":"168","author":"M Hu","year":"2023","unstructured":"Hu M, Li W, Zhang Y, Liang C, Tan J, Wang Y. Venetoclax in adult acute myeloid leukemia. Biomed Pharmacother. 2023;168: 115820.","journal-title":"Biomed Pharmacother"},{"issue":"10","key":"6615_CR83","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1001\/jamaoncol.2024.2662","volume":"10","author":"S Venugopal","year":"2024","unstructured":"Venugopal S, Sekeres MA. Contemporary management of acute myeloid leukemia: a review. JAMA Oncol. 2024;10(10):1417\u201325.","journal-title":"JAMA Oncol"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-06615-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-025-06615-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-06615-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T06:03:25Z","timestamp":1747807405000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-025-06615-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,21]]},"references-count":83,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["6615"],"URL":"https:\/\/doi.org\/10.1186\/s12967-025-06615-y","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,21]]},"assertion":[{"value":"27 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was reviewed and approved by the Ethics Committee of Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, and was carried out in accordance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"566"}}